162 related articles for article (PubMed ID: 17106843)
1. [Neurotoxicity related to lithium-risperidon combination treatment in a patient with schizoaffective disorder].
Böker H; Brandenberger M; Schopper C
Psychiatr Prax; 2007 Jan; 34(1):38-41. PubMed ID: 17106843
[TBL] [Abstract][Full Text] [Related]
2. [Catatonic dilemma in a schizoaffective patient with combined lithium-risperidone administration].
Krähenmann R; Küchenhoff B; Böker H; Schick M
Psychiatr Prax; 2010 Sep; 37(6):306-9. PubMed ID: 20803411
[TBL] [Abstract][Full Text] [Related]
3. Encephalopathy with combined lithium-risperidone administration.
Boora K; Xu J; Hyatt J
Acta Psychiatr Scand; 2008 May; 117(5):394-5; discussion 396. PubMed ID: 18331580
[TBL] [Abstract][Full Text] [Related]
4. Lithium-induced confusional states: nonconvulsive status epilepticus or triphasic encephalopathy?
Kaplan PW; Birbeck G
Epilepsia; 2006 Dec; 47(12):2071-4. PubMed ID: 17201705
[TBL] [Abstract][Full Text] [Related]
5. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
Peschel O; Kurtz G; Müller-Felber W; Modell S
Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573
[TBL] [Abstract][Full Text] [Related]
6. Severe depression with risperidone-induced EPS in an elderly schizoaffective patient.
Benazzi F
Can J Psychiatry; 1996 Apr; 41(3):196-7. PubMed ID: 8722655
[No Abstract] [Full Text] [Related]
7. [Lithium intoxications at normal serum levels].
Habermeyer B; Hess M; Kozomara-Hocke P; Mager R; Kawohl W
Psychiatr Prax; 2008 May; 35(4):198-200. PubMed ID: 17987544
[TBL] [Abstract][Full Text] [Related]
8. High-dose vitamin E plus vitamin B6 treatment of risperidone-related neuroleptic malignant syndrome.
Dursun SM; Oluboka OJ; Devarajan S; Kutcher SP
J Psychopharmacol; 1998; 12(2):220-1. PubMed ID: 9694035
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome induced by low dose aripiprazole in first episode psychosis.
Evcimen H; Alici-Evcimen Y; Basil B; Mania I; Mathews M; Gorman JM
J Psychiatr Pract; 2007 Mar; 13(2):117-9. PubMed ID: 17414689
[No Abstract] [Full Text] [Related]
10. [Neurotoxicity in treatment with lithium. A case report and EEG findings].
García-Solana MI; Rodrigo-Sesma A; García-Rodríguez V; Lloret-Alcañiz MA; Selles-Galiana F; Giménez-Rodríguez P; Mora-Rodríguez E; Medrano-Tovar L; Ferrandis-Ballester F
Rev Neurol; 2004 Sep 16-30; 39(6):595-7. PubMed ID: 15468003
[No Abstract] [Full Text] [Related]
11. Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
Kosehasanogullari SG; Akdede B; Akvardar Y; Akan M; Tunca Z
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1147-8. PubMed ID: 17513032
[No Abstract] [Full Text] [Related]
12. Neuroleptic malignant syndrome and risperidone: a case report.
Bonwick RJ; Hopwood MJ; Morris PL
Aust N Z J Psychiatry; 1996 Jun; 30(3):419-21. PubMed ID: 8839956
[TBL] [Abstract][Full Text] [Related]
13. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
14. [Neuroleptic malignant syndrome and acute life-threatening catatonia--two contrasting disease entities?].
Heils A; Lesch KP
Fortschr Neurol Psychiatr; 1997 Jan; 65(1):8-15. PubMed ID: 9132369
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases].
Sczesni B; Becker H; Schröder J; Bittkau S; von Baumgarten F; Truong DD; Przuntek H
Wien Klin Wochenschr; 1991; 103(1):21-6. PubMed ID: 1673042
[No Abstract] [Full Text] [Related]
16. [Cerebellar degeneration following acute lithium intoxication].
Roy M; Stip E; Black D; Lew V; Langlois R
Rev Neurol (Paris); 1998 Jul; 154(6-7):546-8. PubMed ID: 9773090
[TBL] [Abstract][Full Text] [Related]
17. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
18. Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability.
Thyssen A; Remmerie B; D'Hoore P; Kushner S; Mannaert E
Clin Ther; 2007 Feb; 29(2):290-304. PubMed ID: 17472821
[TBL] [Abstract][Full Text] [Related]
19. Neurotoxicity and nephrotoxicity caused by combined use of lithium and risperidone: a case report and literature review.
Hsu CW; Lee Y; Lee CY; Lin PY
BMC Pharmacol Toxicol; 2016 Dec; 17(1):59. PubMed ID: 27964751
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and safety of combination therapy with lithium and risperidone.
Demling JH; Huang ML; Remmerie B; Mannaert E; Sperling W
Pharmacopsychiatry; 2006 Nov; 39(6):230-1. PubMed ID: 17124646
[No Abstract] [Full Text] [Related]
[Next] [New Search]
